http://bmj.com/cgi/content/abstract/323/7312/533

 

Abridged text of this article

PDF [abridged] of this article

Full text of this article

PDF of this article

Email this article to a friend

Send a response to this article

See related This week in BMJ item

Related editorials in BMJ

PubMed citation

Related articles in PubMed

Download to Citation Manager

Search Medline for articles by:
Bedford, H. || Harvey, D.

Alert me when:
New articles cite this article

Collections under which this article appears:
Other Infectious Diseases
Other Neurology
Other Pediatrics

BMJ 2001;323:533 ( 8 September )

Papers

Meningitis in infancy in England and Wales: follow up at age 5 years

Helen Bedford, senior research fellow, a John de Louvois, director, b Susan Halket, senior scientist, c Catherine Peckham, professor of paediatric epidemiology, a Rosalinde Hurley, professor of microbiology, c David Harvey, professor of paediatrics and neonatal medicine. c

a Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, London WC1N 1EH, b Public Health Laboratory Service, Environmental Surveillance Unit, London NW9 5EQ, c The Karim Centre for Meningitis Research, Imperial College School of Medicine, Department of Paediatrics and Neonatal Medicine, Queen Charlotte's and Chelsea Hospital, London W6 OXG

Correspondence to: H Bedford h.bedford@ich.ucl.ac.uk

Objective: To describe important sequelae occurring among a cohort of children aged 5 years who had had meningitis during the first year of life and who had been identified by a prospective national study of meningitis in infancy in England and Wales between 1985 and 1987.
Design: Follow up questionnaires asking about the children's health and development were sent to general practitioners and parents of the children and to parents of matched controls. The organism that caused the infection and age at infection were also recorded.
Setting: England and Wales.
Participants: General practitioners and parents of children who had had meningitis before the age of 1 year and of matched controls.
Main outcome measures: The prevalence of health and developmental problems and overall disability among children who had had meningitis compared with controls.
Results: Altogether, 1584 of 1717 (92.2%) children who had had meningitis and 1391 of 1485 (93.6%) controls were successfully followed up. Among children who survived to age 5 years 247 of 1584 (15.6%) had a disability; there was a 10-fold increase in the risk of severe or moderate disability at 5 years of age among children who had had meningitis (relative risk 10.3, 95% confidence interval 6.7 to 16.0, P<0.001). There was considerable variation in the rates of severe or moderate disability in children infected with different organisms.
Conclusion: The long term consequences of having meningitis during the first year of life are significant: 32 of 1717 (1.8%) children died within five years. Not only did almost a fifth of children with meningitis have a permanent, severe or moderately severe disability, but subtle deficits were also more prevalent.


What is already known on this topic
Meningitis in infancy is associated with important long term consequences

There is considerable variation in outcome depending on which organism caused the infection

What this study adds
This follow up study of 1717 children who had meningitis in infancy found that they had a 10-fold increase in risk of severe or moderate disabilities at age 5 years compared with children in the control group

The outcome of having meningitis was associated with the age at infection, and children who had meningitis in the neonatal period were more likely to have health and development problems than those older than 1 month

Subtle deficits, such as middle ear disease and visual and behavioural problems, were more prevalent among children who had had meningitis in infancy



 

© BMJ 2001

Related editorials in BMJ:

Legacy of bacterial meningitis in infancy.

Keith Grimwood
BMJ 2001 323: 523-524. [Full text]  

 

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.